◼ Archived
Business
🔮 holds ✗
Merck
7 independently sourced, verified news trends involving Merck.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Jul 16, 2026 through Oct 6, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Business
🔮 holds ✗
Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal
◼ Archived
Business
🔮 holds ✗
Merck sees pivotal victory for $3B eye disease prospect
◼ Archived
Business
🔮 holds ✗
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
◼ Archived
Business
🔮 holds ✗
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.
◼ Archived
Business
🔮 holds ✗
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline
Merck raised its sales forecast while cutting profit guidance following recent acquisition charges.
◼ Archived
Business
🔮 holds ✓
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has approved Lipfendra, the first-of-its-kind oral PCSK9 inhibitor designed to significantly reduce cholesterol levels.